SJS Investment Consulting’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64K Sell
19
-10
-34% -$877 ﹤0.01% 1852
2026
Q1
$2.62K Buy
29
+7
+32% +$642 ﹤0.01% 1208
2025
Q4
$1.98K Buy
22
+10
+83% +$948 ﹤0.01% 1152
2025
Q3
$1.18K Buy
12
+10
+500% +$991 ﹤0.01% 961
2025
Q2
$183 Sell
2
-13
-87% -$1.26K ﹤0.01% 1391
2025
Q1
$1.7K Sell
15
-2
-12% -$214 ﹤0.01% 794
2024
Q4
$1.8K Sell
17
-94
-85% -$10.1K ﹤0.01% 753
2024
Q3
$12K Buy
111
+96
+640% +$10.5K ﹤0.01% 348
2024
Q2
$1.63K Sell
15
-2
-12% -$236 ﹤0.01% 823
2024
Q1
$2.24K Hold
17
﹤0.01% 693
2023
Q4
$2.07K Hold
17
﹤0.01% 653
2023
Q3
$1.91K Sell
17
-4
-19% -$508 ﹤0.01% 656
2023
Q2
$3.06K Buy
21
+1
+5% +$136 ﹤0.01% 459
2023
Q1
$2.58K Buy
20
+1
+5% +$126 ﹤0.01% 522
2022
Q4
$2.42K Sell
19
-2
-10% -$232 ﹤0.01% 547
2022
Q3
$2K Buy
+21
New +$2.31K ﹤0.01% 568
2022
Q1
$0 Buy
+3
New +$362 ﹤0.01% 1409

Other funds holding ZBH

SJS Investment Consulting's ZBH Position: Q2 2026 in Review

SJS Investment Consulting reduced its Zimmer Biomet (ZBH) stake by 34% in Q2 2026, selling an estimated $877 and leaving 19 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

SJS Investment Consulting first reported a position in ZBH in Q1 2022 and has held it in 17 quarters since. The position peaked at $12K in Q3 2024. 522 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • SJS Investment Consulting held 19 shares of Zimmer Biomet worth $1.64K as of Q2 2026.
  • SJS Investment Consulting sold 10 Zimmer Biomet shares in Q2 2026, an estimated $877.
  • Zimmer Biomet made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1852 holding.
  • SJS Investment Consulting first reported a position in Zimmer Biomet in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Zimmer Biomet position peaked at $12K in Q3 2024.
  • 522 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.